Latest Clinical & Research News
Specialty: Endocrinology
Few surgeons perform metabolic surgery for type 2 diabetes treatment, citing inadequate evidence, and for the same reason, many health insurance plans don’t cover it. Long-term supportive efficacy data from the largest randomized cohort has been published.
Read More...
A growing set of low-risk cancers, including early-stage thyroid and kidney cancers, is associated with excellent outcomes regardless of management strategy. Given the risks associated with overtreatment of these cancers, it follows that many patients should be treated nonoperatively. Read More
In the first large, population-based cohort study of the issue, researchers at Brigham and Women’s Hospital found 22% of eligible patients declined statin therapy initially and 6% never accepted the recommendation. Results on both measures were significantly higher for women than men.
Read More...
The Brigham’s Anand Vaidya, MD, MMSc, and Jenifer Michelle Brown, MD, have led studies showing that primary aldosteronism (PA) is much more prevalent than assumed—and may be a causative mechanism for 15%–24% of primary hypertension cases. Now, they are expanding PA screening among high-risk patient populations.
Read More...
Electronic health records (EHRs) have multiple benefits for both clinicians and patients, but can lead to clinician burnout. Martin Kathrins, MD, and Anna Goldman, MD, of Brigham and Women’s Hospital, discuss how EHRs can optimize the treatment of hypogonadal men.
Read More...
Brigham researchers reinforce previous studies showing LSD1 heterozygote knockout mice displayed altered aldosterone secretion/MR activation in an age- and sex-dependent manner, and for the first time, they report that even at the level of aldosterone biosynthesis, there is an effect of biological sex.
Read More...
Researchers in the Division of Endocrinology, Diabetes and Hypertension at Brigham and Women’s Hospital found thyroid-stimulating immunoglobulin bioassay (TSI) and thyrotropin-binding inhibitory immunoglobulin assay (TBII) performed similarly for discriminating Graves’ disease from other causes of thyrotoxicosis.
Read More...
Brigham and Women’s Hospital team has developed an automated two-way text messaging program designed to encourage self-monitoring of blood glucose in women with gestational diabetes mellitus.
Read More...
In this Medical Grand Rounds presentation, Naomi D.L. Fisher, MD, of Brigham and Women’s Hospital, joined a panel of colleagues from the Boston area to discuss recent developments in the diagnosis and treatment of hypertension among older adults.
Read More...
Colleagues from the Brigham’s Center for Adrenal Disorders assessed the efficacy of aldosterone antagonism with a mineralocorticoid receptor (MR) antagonist versus placebo in patients with primary hyperparathyroidism (P-HPT). They provide evidence that MR antagonists have no meaningful role in P‐HPT treatment.
Read More...